145593-91-5Relevant articles and documents
3-deoxy oligosaccharides and pharmaceutical compositions containing them
-
, (2008/06/13)
The invention relates to 3-deoxy oligosaccharides of formula I: STR1 in which X represents an --OSO3- radical, a radical of formula R--O, a radical of formula: STR2 or a radical of formula: STR3 Y represents a radical of formula: STR4 R represents an alkyl radical, R1, R3, R5, R7, R8, R10, R12 and R13 represent a hydroxyl radical, an alkoxy radical or an --OSO3- radical, R2, R4, R6, R9 and R11 represent a hydrogen atom, a hydroxyl radical, an alkoxy radical or an --OSO3- radical, with the proviso that at least R2 or R4 or R6 or R9 or R11 represents a hydrogen atom, and their pharmaceutically acceptable salts with a base.
110. Warum Pentose- und nicht Hexose-Nucleinsaeuren? (Teil II) Oligonucleotide aus 2',3'-Dideoxy-β-D-glucopyranosyl-Bausteinen ('Homo-DNS'): Herstellung - Why Pentose and Not Hexose Nucleic Acids? Part II. Preparation of Oligonucleotides Containing 2',3'-
Boehringer, Markus,Roth, Hans-Joerg,Hunziker, Juerg,Goebel, Michael,Krishnan, Ravichandran,et al.
, p. 1416 - 1477 (2007/10/02)
This paper describes the preparation of the 2',3'-dideoxy-β-D-glucopyranosyl-(= 2',3'-dideoxy-β-D-erythro-hexapyranosyl)-derived nucleosides of the five bases adenine, cytosine, guanine, thymine, and uracil (= 'homo-deoxyribonucleosides') as well as the s